Conference abstractPublished 30 Nov 2015
Terminalia arjuna modulates IL-18 induced inflammation in human monocytic cell line and in patients with stable coronary artery disease
Postgraduate Institute of Medical Education and Research (PGIMER), India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The bark extract of Terminalia arjuna is used traditionally, as a cardio protective agent in Ayurvedic system of medicine. Coronary artery disease (CAD) attracts morbidity and mortality worldwide and inflammation plays a pivotal role in pathophysiology of CAD. Besides use of several drugs like statins, inflammation persists in these patients. The present study demonstrates the antiinflammatory and cardio protective effects of Terminalia arjuna in vitro in a human monocytic cell-line (THP-1 cells and its validation in stable patients of coronary artery disease. THP-1 cells were exposed to pro-inflammatory cytokine IL-18 and the effect of an aqueous extract of Terminalia arjuna was evaluated in vitro on the expression of inflammatory molecules.The observations of the invitro study were further validated in a randomized, placebo-controlled, double-blind clinical trial in 50 subjects with stable CAD who received either placebo or T. arjuna (500 mg twice a day; Himalaya) and were followed up to 6 months. Expression of inflammatory genes e.g. CXCL3, COX-2, DUSP-1 and OSM were significantly reduced in-vitro in a dose and time-dependent manner by Terminalia arjuna. TA utilized MAPKs and NF-Ã?Â?B pathways for its mode of action. These findings were validated in Medicated stable-CAD patients who were given Terminalia arjuna. Our data advocates use of Terminalia arjuna as an adjuvant therapy that helps to prevent and ameliorate CAD via its anti-inflammatory and cardio protective effects. Future studies are warranted in a larger population setup using Terminalia arjuna as an adjuvant therapy to assess its efficacy.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Veena Dhawan”
- BylineArticles whose byline prints “Divya Kapoor”
- BylineArticles whose byline prints “Dimple Trikha”
- BylineArticles whose byline prints “Rajesh Vijayvergiya”
- BylineArticles whose byline prints “K K Parashar”
